The industry is increasingly under attack by lawmakers from both parties for drug prices most Americans regard as unreasonable, so the election outcome could be pivotal to drug companies’ fortunes.
The post For Big Pharma, Trump vs. Harris Is a Clash Between Two Industry Foes appeared first on MedCity News.
